Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 248,000 | 249,000 | 266,000 | 251,000 | 0 |
| Cost of Goods | 25,000 | 24,000 | 24,000 | 24,000 | N/A |
| Gross Profit | 223,000 | 225,000 | 242,000 | 227,000 | N/A |
| Operating Expenses | 185,000 | 147,000 | 127,000 | 112,000 | 0 |
| Operating Income | 38,000 | 78,000 | 115,000 | 115,000 | N/A |
| Interest Expense | 13,000 | 16,000 | 19,000 | 13,000 | 0 |
| Pre-tax Income | 25,000 | 62,000 | 96,000 | 102,000 | 0 |
| Income Tax | -12,000 | 14,000 | 30,000 | 25,000 | N/A |
| Net Income Continuous | 37,000 | 48,000 | 66,000 | 77,000 | N/A |
| Net Income | $37,000 | $48,000 | $66,000 | $77,000 | $N/A |
| EPS Basic Total Ops | 0.25 | 0.35 | 0.45 | 0.55 | N/A |
| EPS Basic Continuous Ops | 0.26 | 0.33 | 0.46 | 0.54 | N/A |
| EPS Diluted Total Ops | 0.20 | 0.35 | 0.45 | 0.55 | N/A |
| EPS Diluted Continuous Ops | 0.25 | 0.33 | 0.45 | 0.53 | N/A |
| EBITDA(a) | $52,000 | $84,000 | $121,000 | $121,000 | $N/A |